Literature DB >> 31662704

Corrigendum to "CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy".

Jing Zhao1, Hong-Liang Rui1, Min Yang1, Li-Jun Sun1, Hong-Rui Dong1, Hong Cheng1.   

Abstract

[This corrects the article DOI: 10.1155/2019/3172647.].
Copyright © 2019 Jing Zhao et al.

Entities:  

Year:  2019        PMID: 31662704      PMCID: PMC6778945          DOI: 10.1155/2019/8247280

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


In the article titled “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy” [1], there were some input errors in Table 3 as the unit of kidney weight “mg,” Lee's index “g/cm,” and urinary protein “mg/d” are wrong and should be corrected as kidney weight “g,” Lee's index “g1/3/cm,” and urinary protein “μg/d.” The corrected version of Table 3 is as follows:
Table 3

Biological parameters in the different groups at the 12th week ().

GroupControlModel
Body weight (g)28.9 ± 1.831.9 ± 1.9
Kidney weight (g)0.34 ± 0.030.37 ± 0.02
Lee's index (g1/3/cm)16.86 ± 0.3817.64 ± 0.56
Visceral fat index0.02 ± 0.010.05 ± 0.02
Urinary protein (μg/d)801.5 ± 178.91001.7 ± 230.1
Serum creatinine (μmol/L)11.3 ± 0.810.4 ± 1.1
Creatinine clearance rate (mL/min)0.4 ± 0.10.7 ± 0.2
Serum triglyceride (mmol/L)0.5 ± 0.10.9 ± 0.4
Serum cholesterol (mmol/L)2.2 ± 0.43.6 ± 0.3
Blood glucose (mmol/L)9.5 ± 0.69.8 ± 1.3

∗ P < 0.05 vs. control group.

The authors apologize for these errors and confirm that they do not affect the conclusions or the results of this article.
  1 in total

1.  CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.

Authors:  Jing Zhao; Hong-Liang Rui; Min Yang; Li-Jun Sun; Hong-Rui Dong; Hong Cheng
Journal:  Mediators Inflamm       Date:  2019-04-11       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.